Physician profile
Michael Shreve
NPI 1700887312
$321.53
in general payments reported to CMS, 2019-2025
10 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.39 · 2022: $43.71 · 2023: $59.60 · 2024: $62.93 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.05 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $85.26 | 2019-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $42.95 | 2024-2025 | Dupixent |
| Astrazeneca Pharmaceuticals Lp | $41.68 | 2023-2025 | Fasenra |
| Amgen INC. | $34.68 | 2022-2025 | Tezspire |
| Genzyme Corporation | $32.12 | 2023-2024 | |
| Baxter Healthcare | $27.26 | 2025 | Hillrom - Synclara Cough System |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
| Electromed, INC. | $15.86 | 2023 | Smartvest |
| Breas Medical, INC. | $12.96 | 2023 | Vivo 45 Ls |
| Philips North America LLC | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Shreve listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.